AstraZeneca CEO hopeful COVID-19 vaccine may still have role in US | Inquirer News
Close  

AstraZeneca CEO hopeful COVID-19 vaccine may still have role in US

/ 06:11 PM July 29, 2021
Pascal Soriot, chief executive of AstraZeneca, attends an interview with Reuters in Shanghai

FILE PHOTO: Pascal Soriot, chief executive of pharmaceuticals company AstraZeneca, attends an interview with Reuters in Shanghai, China, November 4, 2019. REUTERS/Brenda Goh/File Photo

LONDON — AstraZeneca still plans to seek U.S. approval for its COVID-19 vaccine even though the process there is taking longer than expected, because it may still be used in the country in the future, CEO Pascal Soriot said on Thursday.

“The simple answer is, it’s an important vaccine. And we believe it may play a role in the future, so we want to file and get approval for it,” he told a media briefing, when asked why the drugmaker was pursing approval even though the United States has enough supply to inoculate its population without it.

ADVERTISEMENT

Soriot said the company does not need U.S. approval to boost credibility of the vaccine, Vaxzevria, around the world. Some 170 countries have given the go-ahead for its use, but AstraZeneca wants to be ready for a time when it could be needed.

The company’s plans to submit applications for approval have been pushed to the second half of this year, however, after repeated delays because of requests for large data from U.S. authorities.

FEATURED STORIES

“The (U.S.) FDA (Food and Drug Administration) are requesting, an awful lot of information … and we’re having to submit all of those data sets, clinical trial tables analyses, etc. to have that pre-BLA meeting,” senior executive Mene Pangalos said on the call.

The company is also exploring booster doses for people who have already been vaccinated with two doses of either their own shot or mRNA-based vaccines.

“We hope to have that data in the third quarter, suitable for submission with an authorization requests in the UK at least before the end of the year,” Pangalos added.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: AstraZeneca, AstraZeneca CEO Pascal Soriot, coronavirus vaccines, mRNA technology, United States, Vaxzevria
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.